Quantcast

More Monsanto Roundup Cancer Trials Expected to Be Postponed

Health + Wellness
Activists stage a flash protest organized by the international movement Attac at the offices of Bayer in Paris on March 14, 2019. PHILIPPE LOPEZ / AFP via Getty Images

Update, Jan. 8: On Wednesday, St. Louis County Court spokeswoman Christine Bertelson confirmed that one trial set to start Jan. 27 has been officially postponed with no new trial date yet set. That trial was to pit a woman named Sharlean Gordon against Monsanto.

By Carey Gillam

Discussions are underway to postpone one or more highly anticipated Roundup cancer trials set to start in January, including trials scheduled for St. Louis, the former hometown of Roundup herbicide maker Monsanto Co., according to sources close to the litigation.


Court dockets still show trials scheduled for later this month in St. Louis and in California courts, and court officials say they are still planning for the trials to take place on the designated dates. But multiple legal sources said the opposing sides were nearing agreements that would put off the trials by several months, if not longer. Attorneys for Monsanto and for the plaintiffs in the upcoming January trials declined to comment.

The talk of trial delays is not unexpected. Bayer AG, the German company that bought Monsanto in June 2018, successfully negotiated the postponement of several trials that had been set for the fall of 2019 after losing each of the three trials held to date. Each involved plaintiffs who claimed their cancers were caused by exposure to Roundup and other Monsanto glyphosate-based herbicides.

The juries found not just that the company's herbicides can cause cancer, but that Monsanto knew about the risks and hid the information from consumers. Bayer has estimated more than 42,700 people have filed claims in the U.S. against Monsanto, which is now a wholly owned unit of Bayer.

Bayer and a team of plaintiffs' attorneys have been pursuing a potential settlement of the litigation that could amount to well more than $8 billion, the legal sources said.

Bayer has been particularly uneasy about trials scheduled for St. Louis, where former Monsanto CEO Hugh Grant has been subpoenaed to testify and the trial of plaintiff Sharlean Gordon was to be broadcast to the public. In the three previous trials, all held in California, Monsanto executives have given testimony through depositions and have not had to take the stand in front of juries.

"Trial postponements make perfect sense right now," said Susquehanna Financial Group analyst Tom Claps. "I believe that it is in everyone's best interest to stay out of the courtroom at this time, especially when negotiations seem to be progressing in a positive manner."

Amid the maneuvering, more cases continue to stack up. Lawyers for Monsanto were in court Monday in Independence, Missouri to set a schedule and trial date for a newly filed lawsuit brought by a woman suffering from non-Hodgkin lymphoma she claims she developed due to her residential use of Roundup.

Gregory Chernack of the Washington, DC-based Hollingsworth law firm, one of Monsanto's long-serving defense firms, told the judge in Independence that Monsanto wanted the case consolidated with roughly 30 others being overseen by a different judge in Kansas City, Missouri. Attorneys for plaintiff Sheila Carver objected to the suggestion, and asked the judge to go ahead and set a trial date. Jackson County Circuit Court Judge Jennifer Phillips decided to give the parties 30 days to file motions on the matter.

Bayer's annual shareholders' meeting is set for April 28 and analysts said investors would like to see either a settlement of the litigation by that time, or at least meaningful progress in containing the liability. Bayer's stock took a dive, losing billions of dollars in value, after the first jury verdict in August 2018, and share prices remain depressed.

"Bayer's stock has reacted negatively to each of the three trial verdicts. Therefore, Bayer does not want to face more negative trial headlines from losing another trial, especially while it is engaged in good faith settlement discussions," said Claps.

There are multiple factors at play, however, including the uncertainty surrounding the outcome of the appeals that are pending for each of the three trials. If an appellate court were to overturn the jury findings of Monsanto's liability, it would weaken the plaintiffs' bargaining power for a global settlement. Conversely, the company's position would be weakened if the jury verdicts are upheld on appeal. But no decision is expected on the appeals for several more months at least.

In December, the U.S. Department of Justice took the rare step of intervening in the litigation to side with Monsanto and Bayer in the appeal of one of the verdicts.

Reposted with permission from U.S. Right to Know.

EcoWatch Daily Newsletter

Baby orangutan and mother orang utan seen walking in Jakarta, Indonesia. Aprison Photography / Moment / Getty Images

By Tara Lohan

To be a good wildlife photographer, you need an expertly trained eye. But good ears help, too.

Read More
Worker spraying toxic pesticides or insecticides on corn plantation. D-Keine / E+ / Getty Images

Poor people in developing countries are far more likely to suffer from exposure to pesticides classified as having high hazard to human health or the environment, according to new data that Unearthed analyzed.

Read More
Sponsored
Power to heat, to cool, to drive the world's industries. Renewables can supply it all. Jason Blackeye / Unsplash

By Paul Brown

Virtually all the world's demand for electricity to run transport and to heat and cool homes and offices, as well as to provide the power demanded by industry, could be met by renewable energy by mid-century.

Read More
Phthalates, a group of chemicals used to make plastics more flexible and harder to break, affect health in many ways. Tatyana Tomsickova Photography / Moment / Getty Images

By George Citroner

  • Exposure to phthalates was associated with autism traits in boys (but not girls) between ages 3 and 4 years, according to a new study.
  • However, the risk was diminished in women who took folic acid during their pregnancy.
  • This study is the first to find that folic acid supplements provide a protective effect from phthalates.

Exposure in the womb to a group of endocrine-disrupting chemicals called phthalates was associated with autism traits in boys (but not girls) between ages 3 and 4 years, according to a new study.

Read More
A coral and fish community at the Great Barrier Reef, northeast of Port Douglas, Queensland, Australia, on Aug. 28, 2018. Francois Gohier / VWPics / Universal Images Group via Getty Images

Researchers released a sobering study this week showing that all of the world's coral reefs may be lost to the climate crisis by 2100.

Read More